Search

Allergy – what’s in a name?

Allergy is defined as an “abnormal immune reaction to an ordinarily harmless substance” [1], however the meaning of the word has taken many forms since its introduction in 1906 by Austrian Paediatrician and Immunologist, Clemens von Pirquet [2]. Combining his...

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....

In conversation with Prof Peter John Wormald: The past, present and future of treating CRS

At ERS2023, Prof PJ Wormald will lecture on the past, present and future of treating chronic rhinosinusitis (CRS). We caught up with him recently to hear about the major improvements, the hypes and his dreams for the future of treating...

Targeting the microbiome in chronic rhinosinusitis

Researchers at St Paul’s Sinus Centre and UBC in Vancouver are testing a novel treatment for CRS: transferring mucus from a healthy donor into a patient’s sinuses. Chronic rhinosinusitis (CRS) is one of the most common diseases managed by otolaryngologists...

Per-Ingvar Brånemark: father of osseointegration

The application of osseointegration has been central to the development of both bone-anchored hearing aids and dental implants. But how did it all come about? Per-Ingvar Brånemark (1929–2014). Image Johan Wingborg. Many hearing-impaired patients owe a great debt of gratitude...

Lost voices – service induced hearing loss on working age veterans

The Royal British Legion campaign for the recognition of hearing loss in serving personnel and veterans In July 2014, the Royal British Legion launched a report entitled Lost Voices revealing that veterans under the age of 75 are three-and-a-half times...

Rehabilitation of single-sided deafness with cochlear implants

The relatively recent emergence of cochlear implantation as a potential means of restoring hearing to a deafened ear, in the presence of normal hearing in the other ear, has proved an exciting and yet surprising development. James Tysome explores the...

The European TINNET COST Action BM1306

Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...

The search for pharmacological treatments for hearing loss and tinnitus

Where are we in our search for a hearing restoration grail? Nicola Robas leads us through the map pieces discovered in creating a pharmaceutical answer to hearing loss and tinnitus. Together, hearing loss and tinnitus affect over one in six...